A semaglutide tablet licensed for diabetes
Doctors prescribe Rybelsus for type 2 diabetes that is not well enough controlled, alongside diet and exercise. You may take Rybelsus on its own when metformin does not suit you, or with other diabetes medicines. Your team judges its value by your glucose control, side effects and wider health. Your appetite or weight may change during treatment, but the licensed use stays the same.
Why the way you take Rybelsus matters
Semaglutide is a peptide, and the gut absorbs peptides poorly. Rybelsus is designed to make absorption by mouth possible, but food, the amount of water and timing all affect how much you absorb. So you cannot take Rybelsus casually with breakfast. The instructions for taking the tablet form part of the treatment itself.
Rybelsus and Wegovy tablets are separate products
Both products contain semaglutide, but each has its own licence and dosing schedule. The Wegovy tablet gained UK approval for weight management in June 2026. That approval does not turn Rybelsus into a licensed obesity treatment. Never swap one product for the other because the numbers on the boxes match. A prescriber must check the right form and plan.
The change to newer strengths
Newer Rybelsus strengths use a formulation your body absorbs better. MHRA has highlighted the risk of medication errors when people move between the older and newer strength ranges. A smaller milligram number may give the same effect, so a lower number does not always mean your treatment has been cut. Ask the pharmacy to explain any change in strength, and do not keep old and new tablets together in an unlabelled container.
Your daily routine and medical review
Think about whether an empty-stomach morning routine works alongside your other medicines. Tell your clinician about shift work, trouble swallowing or other tablets with their own timing rules. A pharmacist will help you plan the schedule. If your diabetes control is disappointing, review how you take the tablet and whether you take every dose, as well as the prescribed dose. Never take extra tablets to make up for poor absorption.
Safety rules still apply to the tablet
Taking semaglutide by mouth leaves its main precautions in place. Do not ignore severe stomach pain that will not go away, being unable to keep fluids down or a sudden drop in vision. If you take insulin or a sulfonylurea, you need advice about low glucose. Never stop insulin suddenly because you have started Rybelsus. Keep the current leaflet with the pack and make sure a named prescribing service handles your follow-up.
Check your routine works in real life
You may understand the instructions and still struggle to follow them because of caring duties, rotating shifts or a complicated morning medicine schedule. Tell your prescriber what an ordinary day looks like. Tackling that practical problem helps more than assuming poor results mean you are not trying. The plan might include help from a pharmacist or a different treatment. Do not hide missed tablets to keep your prescription. Accurate information helps your clinician avoid needless dose increases and find a routine you can keep up.
Sources
Your own medicine leaflet and prescriber come first. A source from another country does not mean the same rule applies in the UK.
- Rybelsus: UK prescribing information medicines.org.uk
- MHRA: Rybelsus formulation transition gov.uk
- MHRA: UK approval of Wegovy tablets gov.uk
- MHRA: semaglutide and NAION gov.uk
- MHRA: GLP-1 medicines and rapid insulin reduction gov.uk
Spotted something out of date? Report a mistake.